Answers are grounded in this paper and cite their sources.
The aim: The discovery of so-called CFTR modulators has set a new milestone in the treatment of cystic fibrosis (CF) for patients with F508del mutations. Methods: The impact of modulatory therapy on glycoregulation in patients with CF before and one year after the introduction of therapy. Results: 16 patients were treated at the Clinic for Children's Diseases in Banja Luka, clinical, microbiological characteristics, as well as continuous glucose measurement by placing a glucometer were monitored during 12 months of therapy. Conclusion: The use of a glucose sensor proved to be a superior method compared to OGTT in the treatment of glycoregulation disorders in our patients.
No takes yet. Share an insight, caveat, or question.
Ljuboja et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: